반응식
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[CH:16](O)[C:10]3[N:11]=[C:12]([CH3:15])[N:13]([CH3:14])[C:9]=3[CH:8]=[CH:7][C:6]=2[CH:18]=1.[CH3:19][N:20]1[CH:27]=[CH:26][C:24](=[O:25])[NH:23][C:21]1=[O:22].B(F)(F)F.CCOCC.CO>C(#N)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[CH:16]([C:26]3[C:24](=[O:25])[NH:23][C:21](=[O:22])[N:20]([CH3:19])[CH:27]=3)[C:10]3[N:11]=[C:12]([CH3:15])[N:13]([CH3:14])[C:9]=3[CH:8]=[CH:7][C:6]=2[CH:18]=1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
반응 조건
- 온도
- 50 °C
실험 절차
A mixture of the product from step (iii) (0.91 g), and 1-methyluracil (0.44 g) in acetonitrile (40 ml) was treated with boron trifluoride etherate (2.47 g) and heated at 50° C. for 4 h. The solution was treated with methanol (1 ml) and evaporated. Purification was by chromatography on a biotage silica column, using 3% methanol/0.1% 0.880 ammonia in dichloromethane as eluant to give the subtitled product as a cream powder.
후처리
- customevaporated
- customPurification
출처 및 근거
- ORD 기록
- ord-24895a3d2b4044ac8a8aafa6ec8d6d06
- 출처 데이터셋
- uspto-grants-2001_04
- 특허 번호
- US06218376B1
연결된 노트
불러오는 중…